A. Wagg, B. Franks, B. Ramos, and T. Berner, “Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada”, CUAJ, vol. 9, no. 9-10, pp. 343–50, Oct. 2015.